Biomarkers Europe 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences
Sanofi at Biomarkers Europe 2026
Oct 13–14, 2026 Basel, Switzerland ~1k attendees Website
Sanofi takes part in 2 sessions at Biomarkers Europe 2026 in Basel. Its sessions cover biomarker discovery in early drug research and predicting how clinical trials will turn out. One uses mass spectrometry imaging of tissue to find safety and drug-action biomarkers without a preset target list, and another combines drug-level and biomarker data to forecast trial results.
| Organization | Biomarkers Europe 2026 Attendance |
|---|---|
Sanofi Paris, France | |
French pharmaceutical company with medicines and vaccines in immunology, rare diseases, neurology and oncology. | Talk Tue Oct 13 11:50am–12:15pm Untargeted Biomarker Discovery For Toxicological & Pharmacological Investigations In Pre-Clinical Drug Discovery Programs By Spatial Tissue Mass Spectroscopy Imaging Platform Biomarker discovery & translationDigital pathology & spatial biomarkers Talk Tue Oct 13 12:15pm–12:40pm Clinical Trial Outcome Prediction Through Systematic Data Enrichment: Integrating Pharmacokinetic And Biomarker Data Multimodal & AI-enabled precision medicine |
Instantly find 20 buyers from Sanofi
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by Biomarkers, CDx & Precision Medicine or its organizers. Submit a correction